Plasma distribution and signaling activities of IGF-II precursors

Endocrinology

Volumn 152, Issue 3, 2011, Pages 922-930

  Marks, Alicia G ^a   Carroll, Julie M ^c   Purnell, Jonathan Q ^b   Roberts Jr , Charles T ^a,b,c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN RECEPTOR; INSULIN RECEPTOR SUBSTRATE 2; PROTEIN KINASE B; SOMATOMEDIN BINDING PROTEIN 2;

ADULT; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; ENZYME ACTIVATION; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ADULT; AGED; ANIMALS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HAPLORHINI; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LYMPHOMA, LARGE-CELL, IMMUNOBLASTIC; MALE; MICE; MIDDLE AGED; PROTEIN ISOFORMS; RATS; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 79951861980     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-0784     Document Type: Article

References (29)

1. Daughaday WH, Emanuele MA, Brooks MH, Barbato AL, Kapadia M, Rotwein P 1988 Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia.NEngl J Med 319:1434-1440
2. de Groot JW, Rikhof B, van Doorn J, Bilo HJ, Alleman MA, Honkoop AH, van der Graaf WT 2007 Non-islet cell tumour-induced hypoglycaemia: a review of the literature includingtwonewcases. Endocr Relat Cancer 14:979-993 (Pubitemid 351252430)
3. Zapf J, Futo E, Peter M, Froesch ER 1992 Can "big" insulin-like growth factor II in serum of tumor patients account for the development of extrapancreatic tumor hypoglycemia? J Clin Invest 90: 2574-2584
4. Hudgins WR, Hampton B, Burgess WH, Perdue JF 1992 The identification of O-glycosylated precursors of insulin-like growth factor II. J Biol Chem 267:8153-8160
5. Duguay SJ, Jin Y, Stein J, Duguay AN, Gardner P, Steiner DF 1998 Post-translational processing of the insulin-like growth factor-2 precursor. Analysis of O-glycosylation and endoproteolysis. J Biol Chem 273:18443-18451 (Pubitemid 28334772)
6. van Doorn J, Hoogerbrugge CM, Koster JG, Bloemen RJ, Hoekman K, Mudde AH, van Buul-Offers SC 2002 Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia. Clin Chem 48:1739-1750
7. Daughaday WH, Trivedi B 1992 Measurement of derivatives of proinsulin-like growth factor-II in serum by a radioimmunoassay directed against the E-domain in normal subjects and patients with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 75:110-115
8. Rinderknecht E, Humbel RE 1978 Primary structure of human insulin-like growth factor II. FEBS Lett 89:283-286 (Pubitemid 8340912)
9. Denley A, Bonython ER, Booker GW, Cosgrove LJ, Forbes BE, Ward CW, Wallace JC 2004 Structural determinants for high-affinity binding of insulin-like growth factor II to insulin receptor (IR)-A, the exon 11 minus isoform of the IR. Mol Endocrinol 18: 2502-2512 (Pubitemid 39335984)
10. DeMeyts P, Whittaker J 2002 Structural biology of insulin and IGF1 receptors: implications for drug design. Nat Rev Drug Discov 1:769-783 (Pubitemid 37361561)
11. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R 1999 Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19:3278-3288 (Pubitemid 29193789)
12. Valenzano KJ, Heath-Monnig E, Tollefsen SE, Lake M, Lobel P 1997 Biophysical and biological properties of naturally occurring high molecular weight insulin-like growth factor II variants. J Biol Chem 272:4804-4813 (Pubitemid 27090026)
13. White MF, Shoelson SE, Keutmann H, Kahn CR 1988 A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor. J Biol Chem 263:2969-2980 (Pubitemid 18062952)
14. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R 2009 Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30:586-623
15. Araki E, Lipes MA, Patti ME, Bruning JC, Haag 3rd B, Johnson RS, Kahn CR 1994 Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186-190 (Pubitemid 24347839)
16. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers Jr MG, Glasheen E, Lane WS, Pierce JH, White MF 1995 Role of IRS-2 in insulin and cytokine signalling. Nature 377:173-177
17. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA 1996 Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J 15:6541-6551 (Pubitemid 26413787)
18. Daughaday WH, Kapadia M 1989 Significance of abnormal serum binding of insulin-like growth factor II in the development of hypoglycemia in patients with non-islet-cell tumors. Proc Natl Acad Sci USA 86:6778-6782
19. Qiu Q, Jiang JY, Bell M, Tsang BK, Gruslin A 2007 Activation of endoproteolytic processing of insulin-like growth factor-II in fetal, early postnatal, and pregnant rats and persistence of circulating levels in postnatal life. Endocrinology 148:4803-4811 (Pubitemid 47481519)
20. Zachariah S, Brackenridge A, Shojaee-Moradie F, Camuncho-Hubner C, Umpleby AM, Russell-Jones D 2007 The mechanismof non-islet cell hypoglycaemia caused by tumour-produced IGF-II. Clin Endocrinol (Oxf) 67:637-638 (Pubitemid 47416324)
21. Baxter RC, Holman SR, Corbould A, Stranks S, Ho PJ, Braund W 1995 Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 80:2700-2708
22. Bond JJ, Meka S, Baxter RC 2000 Binding characteristics of proinsulin-like growth factor-II from cancer patients: binary and ternary complex formation with IGF binding proteins-1 to -6. J Endocrinol 165:253-260 (Pubitemid 30341074)
23. Purnell JQ, Brandon DD, Isabelle LM, Loriaux DL, Samuels MH 2004 Association of 24-hour cortisol production rates, cortisolbinding globulin, and plasma-free cortisol levels with body composition, leptin levels, and aging in adult men and women. J Clin Endocrinol Metab 89:281-287 (Pubitemid 38183894)
24. Pandini G, Frasca F, Mineo R, Sciacca L, Vigneri R, Belfiore A 2002 Insulin/insulin-like growth factor I hybrid receptors have different biological characteristics depending on the insulin receptor isoform involved. J Biol Chem 277:39684-39695 (Pubitemid 35190951)
25. Denley A, Brierley GV, Carroll JM, Lindenberg A, Booker GW, Cosgrove LJ, Wallace JC, Forbes BE, Roberts Jr CT 2006 Differential activation of insulin receptor isoforms by insulin-like growth factors is determined by the C domain. Endocrinology 147:1029-1036 (Pubitemid 43113023)
26. Denley A, Carroll JM, Brierley GV, Cosgrove L, Wallace J, Forbes B, Roberts Jr CT 2007 Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors. Mol Cell Biol 27:3569-3577 (Pubitemid 46726168)
27. Qiu Q, Yan X, Bell M, Di J, Tsang BK, Gruslin A 2010 Mature IGF-II prevents the formation of "big" IGF-II/IGFBP-2 complex in the human circulation. Growth Horm IGF Res 20:110-117
28. Agus MS, Katz LE, Satin-Smith M, Meadows AT, Hintz RL, Cohen P 1995 Non-islet-cell tumor associated with hypoglycemia in a child: successful long-term therapy with growth hormone. J Pediatr 127: 403-407
29. Katz LE, Liu F, Baker B, Agus MS, Nunn SE, Hintz RL, Cohen P 1996 The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia. J Clin Endocrinol Metab 81:1141-1146 (Pubitemid 26083983)